AERIE PHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aerie Pharmaceuticals Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2022.
  • Aerie Pharmaceuticals Inc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2022 was $20.8M, a 10.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $20.8M -$2.41M -10.4% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $21.6M +$8.73M +68% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $21.9M +$8.68M +65.5% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $22.7M +$8.59M +61% Dec 31, 2021 10-Q 2022-11-04
Q3 2021 $23.2M +$8.13M +54.1% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $12.8M -$2.08M -13.9% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $13.2M -$2.22M -14.4% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $14.1M -$2.44M -14.8% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $15M -$2.18M -12.6% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $14.9M -$2.98M -16.6% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $15.5M -$929K -5.67% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $16.5M +$16.5M Dec 31, 2019 10-K 2021-02-26
Q3 2019 $17.2M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $17.9M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $16.4M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $0 Dec 31, 2018 10-Q 2019-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.